Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
36 participants
INTERVENTIONAL
2016-06-01
2018-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
NCT05379959
Effects of MDMA and Methylphenidate on Social Cognition
NCT01616407
Prosocial Effects of MDMA
NCT05948683
Effects of MDMA on Social and Emotional Processing
NCT01849419
Emotional Effects of Methylphenidate and MDMA in Healthy Subjects
NCT01465685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Subjects will attend one session during which they will receive a placebo capsule.
3,4-Methylenedioxymethamphetamine
Participants will be given 0.75mg/kg of 1.5mg/kg MDMA
methamphetamine
Please see above.
Low dose MDMA
Subjects will attend one session during which they will receive 0.75mg/kg MDMA.
3,4-Methylenedioxymethamphetamine
Participants will be given 0.75mg/kg of 1.5mg/kg MDMA
methamphetamine
Please see above.
High dose MDMA
Subjects will attend one session during which they will receive 1.5mg/kg MDMA.
3,4-Methylenedioxymethamphetamine
Participants will be given 0.75mg/kg of 1.5mg/kg MDMA
methamphetamine
Please see above.
Methamphetamine
Subjects will attend one session during which they will receive 20mg methamphetamine.
3,4-Methylenedioxymethamphetamine
Participants will be given 0.75mg/kg of 1.5mg/kg MDMA
methamphetamine
Please see above.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3,4-Methylenedioxymethamphetamine
Participants will be given 0.75mg/kg of 1.5mg/kg MDMA
methamphetamine
Please see above.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English fluency
* Healthy
* Has used MDMA
Exclusion Criteria
* Any medical or psychiatry condition
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bershad AK, Hsu DT, de Wit H. MDMA enhances positive affective responses to social feedback. J Psychopharmacol. 2024 Mar;38(3):297-304. doi: 10.1177/02698811231224153. Epub 2024 Jan 27.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB15-780
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.